股本结构

单位:万股
公告日期 2025-10-28 2025-10-29 2025-07-28 2025-07-28 2025-05-21 2025-05-21
证券总股本 339.27 262.32 261.18 260.50 240.00 3550.00
普通股本 339.27 262.32 261.18 260.50 240.00 3550.00
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2025-10-30 2025-09-30 2025-07-25 2025-06-30 2025-06-02 2025-05-21
注释:中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本(万股) 变动后优先股(万股) 变动原因 变动日期
2025-10-28 339.27 未披露
更多>>
Common Stock offered 769,490 shares by the company
2025-10-30
2025-10-29 262.32 未披露
更多>>
From June 30, 2025 to September 30, 2025 Equity financing, net Equity incentive plan
2025-09-30
2025-07-28 261.18 未披露 定期报告 2025-07-25
2025-07-28 260.50 未披露
更多>>
From March 31, 2025 to June 30, 2025 Equity financing, net Equity incentive plan
2025-06-30
2025-05-21 240.00 未披露
更多>>
reverse stock split of shares of its common stock at a ratio of 1-for-15
2025-06-02
2025-05-21 3550.00 未披露 定期报告 2025-05-21
2025-05-20 3528.97 未披露 定期报告 2025-05-19
2025-05-05 2904.30 未披露 定期报告 2025-05-02
2025-04-10 2901.77 未披露 定期报告 2025-04-09
2025-05-05 2819.70 未披露
更多>>
From December 31, 2024 to March 31, 2025 Equity incentive plan Equity financing, net Matching contribution to 401(k) plan Exercise of Pre-Funded Warrants
2025-03-31
2025-04-10 2819.67 未披露 定期报告 2025-03-18
2025-03-03 2482.48 未披露 定期报告 2025-02-28
2025-03-03 2220.30 未披露
更多>>
From December 31, 2023 to December 31, 2024 Equity financing, net Exercise of Pre-Funded Warrants Equity incentive plan Matching contribution to 401(k) plan
2024-12-31
2024-10-28 2199.84 未披露 定期报告 2024-10-25
2024-10-28 2199.80 未披露
更多>>
From June 30, 2024 to September 30, 2024 Equity financing, net Exercise of warrants Equity incentive plan
2024-09-30
2024-09-03 2154.42 未披露
更多>>
On August 29, 2024 the company issued 3,100,000 shares common stock
2024-08-29
2024-08-28 1844.42 未披露 定期报告 2024-06-30
2024-04-29 1817.44 未披露 定期报告 2024-04-26
2024-04-26 1809.93 未披露 定期报告 2024-04-10
2024-04-29 1809.60 未披露
更多>>
From December 31, 2023 to March 31, 2024 Equity financing, net Matching contribution to 401(k) plan Equity incentive plan
2024-03-31
2024-03-04 1790.31 未披露 定期报告 2024-03-01
2024-01-12 1781.55 未披露
更多>>
Common stock offered 2,967,742 shares by the company
2024-01-16
2024-03-04 1484.80 未披露
更多>>
From December 31,2022 to December 31,2023 Issuance of common stock under: ATM offering, net of commission and issuance costs of $28 Equity incentive plan Matching contribution to 401(k) plan
2023-12-31
2024-01-12 1484.77 未披露 定期报告 2023-12-29
2024-01-12 1423.48 未披露 定期报告 2023-09-30
2023-07-27 1380.70 未披露 定期报告 2023-07-24
2023-07-27 1380.70 未披露
更多>>
From March 31, 2023 to June 30, 2023 Equity incentive plan Matching contribution to 401(k) plan
2023-06-30
2023-04-28 1350.29 未披露 定期报告 2023-04-14
2023-04-27 1334.20 未披露
更多>>
From December 31, 2022 to March 31, 2023 Equity incentive plan
2023-03-31
2023-03-28 1334.15 未披露 定期报告 2023-03-23
2023-03-28 1320.30 未披露
更多>>
From December 31, 2021 to December 31, 2022 Equity incentive plan Matching contribution to 401(k) plan
2022-12-31
2022-11-03 1314.24 未披露 定期报告 2022-11-01
2022-11-03 1312.70 未披露
更多>>
From June 30, 2022 to September 30, 2022 Issuance of common stock under: Equity incentive plan
2022-09-30
2022-07-28 1302.66 未披露 定期报告 2022-07-26
2022-07-28 1301.00 未披露
更多>>
From March 31, 2022 to June 30, 2022 Issuance of common stock under: Equity incentive plan
2022-06-30
2022-04-29 1284.45 未披露 定期报告 2022-04-14
2022-04-28 1284.40 未披露
更多>>
From December 31, 2021 to March 31, 2022 Matching contribution to 401(k) plan Equity incentive plan
2022-03-31
2022-02-24 1269.29 未披露 定期报告 2022-02-18
2022-02-24 1269.30 未披露
更多>>
From December 31, 2020 to December 31, 2021 Equity financing, net Equity incentive plan Exercise of warrants Matching contribution to 401(k) plan
2021-12-31
2021-11-02 1266.37 未披露 定期报告 2021-10-29
2021-11-02 1266.40 未披露
更多>>
From June 30, 2021 to September 30, 2021 Issuance of common stock under: Equity incentive plan
2021-09-30
2021-07-29 1265.53 未披露 定期报告 2021-07-26
2021-07-29 1265.50 未披露 定期报告 2021-06-30
2021-04-29 1265.50 未披露 定期报告 2021-04-14
2021-04-29 1265.50 未披露
更多>>
from December 31, 2020 to March 31, 2021 Equity financing, net Exercise of warrants Matching contribution to 401(k) plan
2021-03-31
2021-02-25 1259.99 未披露 定期报告 2021-02-19
2021-02-11 1221.87 未披露
更多>>
1.Common Stock Offered by the company 3,902,440 shares. 2.The number of shares of common stock to be outstanding after this offering is based on 8,316,308 shares of common stock outstanding as of September 30, 2020.
2021-02-11
2021-02-25 834.90 未披露
更多>>
From December 31, 2019 to December 31, 2020 Issuance of common stock under: Matching contribution to 401(k) plan In lieu of cash compensation Exercise of warrants Equity incentive plan Equity financing, net Shares issued as a result of rounding due to reverse-stock split
2020-12-31
2021-02-08 831.63 未披露
更多>>
From June 30, 2020 to September 30, 2020 Issuance of common stock under: Equity incentive plan Exercise of warrants
2020-09-30
2020-07-31 827.13 未披露 定期报告 2020-07-28
2020-07-02 781.11 未披露 定期报告 2020-07-01
2020-10-09 781.43 未披露
更多>>
from March 31, 2020 to June 30, 2020 Issuance of common stock under: Equity financing, net Exercise of warrants
2020-06-30
2020-06-16 759.11 未披露 定期报告 2020-06-15
2020-06-10 759.11 未披露
更多>>
1.Common Stock Offered 1,747,704 shares 2.The number of shares of our Common Stock to be outstanding after this offering is based on 5,843,442 shares of our Common Stock outstanding as of March 31, 2020
2020-06-10
2020-06-16 584.34 未披露
更多>>
From December 31, 2019 to March 31, 2020 Issuance of common stock under: Matching contribution to 401(k) plan In lieu of cash compensation Shares issued as a result of rounding due to reverse-stock split
2020-03-31
2020-03-24 582.94 未披露
更多>>
The Reverse Stock Split, and the form of Amendment, were approved by the Company’s stockholders at the Company’s special meeting of stockholders held on March 12, 2020 (the “Special Meeting”), with a split ratio in the range of 1-for-5 and 1-for-15, with the Company’s Board of Directors (the “Board”) authorized to fix the final split ratio within such range. On March 16, 2020, the Board approved the final split ratio for the Reverse Stock Split to be 1-for-15.
2020-03-25
2020-02-27 8705.01 未披露 定期报告 2020-02-21
2020-02-10 8691.95 未披露 定期报告 2020-01-16
2020-02-27 8692.00 未披露
更多>>
From December 31, 2018 to December 31, 2019 Issuance of common stock under: Equity incentive plan Equity financing, net Equipois sales earn-out Matching contribution to 401(k) plan In lieu of employee cash bonus
2019-12-31
2019-12-20 8606.37 未披露
更多>>
1.Common Stock Offered by Us 11,111,116 shares of Common Stock. 2.The number of shares of our Common Stock to be outstanding after this offering is based on 74,952,547 shares of our Common Stock outstanding as of September 30, 2019
2019-12-20
2019-10-30 7495.25 未披露 定期报告 2019-10-25
2019-10-30 7495.30 未披露
更多>>
from June 30, 2019 to September 30, 2019 Issuance of common stock under: Equity incentive plan
2019-09-30
2019-08-01 7491.84 未披露 定期报告 2019-07-29
2019-08-01 7489.50 未披露
更多>>
From March 31, 2019 To June 30, 2019 Issuance of common stock under: Equity financing, net Equity incentive plan In lieu of employee cash bonus
2019-06-30
2019-05-24 7419.53 未披露 定期报告 2019-05-24
2019-04-30 6766.92 未披露 定期报告 2019-04-22
2019-05-01 6752.90 未披露
更多>>
from December 31, 2018 to March 31, 2019 Issuance of common stock under: Equity financing, net Equipois sales earn-out Equity incentive plan Matching contribution to 401(k) plan
2019-03-31
2019-02-28 6425.65 未披露 定期报告 2019-02-21
2019-02-28 6296.30 未披露
更多>>
from December 31, 2017 to December 31, 2018 ATM program, net of commission & issuance costs of $274 Equipois sales earn-out Equity incentive plan Matching contribution to 401(k) plan In lieu of cash compensation
2018-12-31
2018-11-07 6264.23 未披露 定期报告 2018-10-31
2018-11-07 6261.70 未披露 定期报告 2018-09-30
2018-08-07 6083.23 未披露 定期报告 2018-07-31
2018-08-07 6083.20 未披露 定期报告 2018-06-30
2018-04-30 6035.49 未披露 定期报告 2018-04-26
2018-05-07 6035.50 未披露 定期报告 2018-03-31
2018-03-13 6021.62 未披露 定期报告 2018-03-02
2018-03-13 5994.30 未披露
更多>>
from December 31, 2016 to December 31, 2017 Issuance of common stock, net of underwriting discount & issuance costs of $662 Equipois supply and sales earn-outs Issuance of common stock, net of issuance costs of $227 Issuance of common stock upon exercise of warrants Issuance of common stock upon exercise of stock options Issuance of restricted stock
2017-12-31
2017-11-08 5990.39 未披露 定期报告 2017-11-01
2017-11-08 2189.40 未披露 定期报告 2017-09-30
2017-08-07 2578.92 未披露 定期报告 2017-08-01
2017-08-07 2578.90 未披露 定期报告 2017-06-30
2017-06-06 2572.39 未披露 定期报告 2017-05-25
2017-04-28 2563.46 未披露 定期报告 2017-04-25
2017-05-09 2190.20 未披露 定期报告 2017-03-31
2017-03-15 2190.22 未披露 定期报告 2017-03-01
2017-03-15 2189.40 未披露
更多>>
From December 31, 2015 to December 31, 2016 Shares issued as a result of rounding due to reverse-stock split Issuance of common stock, net of underwriting discount & issuance costs of $1,373 Conversion of Series A convertible preferred stock to common stock and accretion of Series A convertible preferred stock discount Deemed dividend on Series A convertible preferred stock Issuance of common stock upon exercise of stock options
2016-12-31
2016-11-09 2188.10 未披露 定期报告 2016-11-02
2016-11-09 2139.30 未披露 定期报告 2016-09-30
2016-08-09 2013.28 未披露
更多>>
Common Stock Offered by us 3,750,000 shares
2016-08-09
2016-08-03 1638.30 0.40 定期报告 2016-06-30
Common Stock offered 769,490 shares by the company
From June 30, 2025 to September 30, 2025 Equity financing, net Equity incentive plan
From March 31, 2025 to June 30, 2025 Equity financing, net Equity incentive plan
reverse stock split of shares of its common stock at a ratio of 1-for-15
From December 31, 2024 to March 31, 2025 Equity incentive plan Equity financing, net Matching contribution to 401(k) plan Exercise of Pre-Funded Warrants
From December 31, 2023 to December 31, 2024 Equity financing, net Exercise of Pre-Funded Warrants Equity incentive plan Matching contribution to 401(k) plan
From June 30, 2024 to September 30, 2024 Equity financing, net Exercise of warrants Equity incentive plan
On August 29, 2024 the company issued 3,100,000 shares common stock
From December 31, 2023 to March 31, 2024 Equity financing, net Matching contribution to 401(k) plan Equity incentive plan
Common stock offered 2,967,742 shares by the company
From December 31,2022 to December 31,2023 Issuance of common stock under: ATM offering, net of commission and issuance costs of $28 Equity incentive plan Matching contribution to 401(k) plan
From March 31, 2023 to June 30, 2023 Equity incentive plan Matching contribution to 401(k) plan
From December 31, 2022 to March 31, 2023 Equity incentive plan
From December 31, 2021 to December 31, 2022 Equity incentive plan Matching contribution to 401(k) plan
From June 30, 2022 to September 30, 2022 Issuance of common stock under: Equity incentive plan
From March 31, 2022 to June 30, 2022 Issuance of common stock under: Equity incentive plan
From December 31, 2021 to March 31, 2022 Matching contribution to 401(k) plan Equity incentive plan
From December 31, 2020 to December 31, 2021 Equity financing, net Equity incentive plan Exercise of warrants Matching contribution to 401(k) plan
From June 30, 2021 to September 30, 2021 Issuance of common stock under: Equity incentive plan
from December 31, 2020 to March 31, 2021 Equity financing, net Exercise of warrants Matching contribution to 401(k) plan
1.Common Stock Offered by the company 3,902,440 shares. 2.The number of shares of common stock to be outstanding after this offering is based on 8,316,308 shares of common stock outstanding as of September 30, 2020.
From December 31, 2019 to December 31, 2020 Issuance of common stock under: Matching contribution to 401(k) plan In lieu of cash compensation Exercise of warrants Equity incentive plan Equity financing, net Shares issued as a result of rounding due to reverse-stock split
From June 30, 2020 to September 30, 2020 Issuance of common stock under: Equity incentive plan Exercise of warrants
from March 31, 2020 to June 30, 2020 Issuance of common stock under: Equity financing, net Exercise of warrants
1.Common Stock Offered 1,747,704 shares 2.The number of shares of our Common Stock to be outstanding after this offering is based on 5,843,442 shares of our Common Stock outstanding as of March 31, 2020
From December 31, 2019 to March 31, 2020 Issuance of common stock under: Matching contribution to 401(k) plan In lieu of cash compensation Shares issued as a result of rounding due to reverse-stock split
The Reverse Stock Split, and the form of Amendment, were approved by the Company’s stockholders at the Company’s special meeting of stockholders held on March 12, 2020 (the “Special Meeting”), with a split ratio in the range of 1-for-5 and 1-for-15, with the Company’s Board of Directors (the “Board”) authorized to fix the final split ratio within such range. On March 16, 2020, the Board approved the final split ratio for the Reverse Stock Split to be 1-for-15.
From December 31, 2018 to December 31, 2019 Issuance of common stock under: Equity incentive plan Equity financing, net Equipois sales earn-out Matching contribution to 401(k) plan In lieu of employee cash bonus
1.Common Stock Offered by Us 11,111,116 shares of Common Stock. 2.The number of shares of our Common Stock to be outstanding after this offering is based on 74,952,547 shares of our Common Stock outstanding as of September 30, 2019
from June 30, 2019 to September 30, 2019 Issuance of common stock under: Equity incentive plan
From March 31, 2019 To June 30, 2019 Issuance of common stock under: Equity financing, net Equity incentive plan In lieu of employee cash bonus
from December 31, 2018 to March 31, 2019 Issuance of common stock under: Equity financing, net Equipois sales earn-out Equity incentive plan Matching contribution to 401(k) plan
from December 31, 2017 to December 31, 2018 ATM program, net of commission & issuance costs of $274 Equipois sales earn-out Equity incentive plan Matching contribution to 401(k) plan In lieu of cash compensation
from December 31, 2016 to December 31, 2017 Issuance of common stock, net of underwriting discount & issuance costs of $662 Equipois supply and sales earn-outs Issuance of common stock, net of issuance costs of $227 Issuance of common stock upon exercise of warrants Issuance of common stock upon exercise of stock options Issuance of restricted stock
From December 31, 2015 to December 31, 2016 Shares issued as a result of rounding due to reverse-stock split Issuance of common stock, net of underwriting discount & issuance costs of $1,373 Conversion of Series A convertible preferred stock to common stock and accretion of Series A convertible preferred stock discount Deemed dividend on Series A convertible preferred stock Issuance of common stock upon exercise of stock options
Common Stock Offered by us 3,750,000 shares